Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Nutt

Showing results (461-470 of 790) with videos related to

Pageof 79
Sort By:
European Journal of Pharmacology|June 22, 1988
RO 15-4513 does not protect rats against the lethal effects of ethanolD J Nutt, R G Lister, D Rusche, et al.
Journal of Psychopharmacology (Oxford, England)|September 20, 2024
Autonomic nervous system activity correlates with peak experiences induced by DMT and predicts increases in well-beingValerie Bonnelle, Amanda Feilding, Fernando E Rosas, et al.
Journal of Psychopharmacology (Oxford, England)|March 30, 2001
Venlafaxine occupation at the noradrenaline reuptake site: in-vivo determination in healthy volunteersJ K Melichar, A Haida, C Rhodes, et al.
European Journal of Pharmacology|August 20, 2005
Characterisation of imidazoline I2 binding sites in pig brainNeil J Anderson, Patrick A Lupo, David J Nutt, et al.
Neurology|July 1, 1992
Time interval between repeated injections conditions the duration of motor improvement to apomorphine in Parkinson's diseaseF Grandas, S Gancher, G Lera, et al.
Biological Psychiatry|August 29, 2006
Resolution of sleepiness and fatigue in major depressive disorder: A comparison of bupropion and the selective serotonin reuptake inhibitorsGeorge I Papakostas, David J Nutt, Lindsay A Hallett, et al.
Psychopharmacology|March 21, 2015
Psychopharmacological characterisation of the successive negative contrast effect in ratsC E Phelps, E N Mitchell, D J Nutt, et al.
European Addiction Research|April 3, 2015
Clinical relevance of as-needed treatment with nalmefene in alcohol-dependent patientsHenri-Jean Aubin, Jens Reimer, David J Nutt, et al.
Psychopharmacology|September 23, 2014
LSD enhances suggestibility in healthy volunteersR L Carhart-Harris, M Kaelen, M G Whalley, et al.
Neuropharmacology|October 17, 2022
Mescaline: The forgotten psychedelicIoanna A Vamvakopoulou, Kelly A D Narine, Ian Campbell, et al.
Pageof 79

Showing results (461-470 of 790) with videos related to

Sort By:
Pageof 79
European Journal of Pharmacology|June 22, 1988
RO 15-4513 does not protect rats against the lethal effects of ethanolD J Nutt, R G Lister, D Rusche, et al.
Journal of Psychopharmacology (Oxford, England)|September 20, 2024
Autonomic nervous system activity correlates with peak experiences induced by DMT and predicts increases in well-beingValerie Bonnelle, Amanda Feilding, Fernando E Rosas, et al.
Journal of Psychopharmacology (Oxford, England)|March 30, 2001
Venlafaxine occupation at the noradrenaline reuptake site: in-vivo determination in healthy volunteersJ K Melichar, A Haida, C Rhodes, et al.
European Journal of Pharmacology|August 20, 2005
Characterisation of imidazoline I2 binding sites in pig brainNeil J Anderson, Patrick A Lupo, David J Nutt, et al.
Neurology|July 1, 1992
Time interval between repeated injections conditions the duration of motor improvement to apomorphine in Parkinson's diseaseF Grandas, S Gancher, G Lera, et al.
Biological Psychiatry|August 29, 2006
Resolution of sleepiness and fatigue in major depressive disorder: A comparison of bupropion and the selective serotonin reuptake inhibitorsGeorge I Papakostas, David J Nutt, Lindsay A Hallett, et al.
Psychopharmacology|March 21, 2015
Psychopharmacological characterisation of the successive negative contrast effect in ratsC E Phelps, E N Mitchell, D J Nutt, et al.
European Addiction Research|April 3, 2015
Clinical relevance of as-needed treatment with nalmefene in alcohol-dependent patientsHenri-Jean Aubin, Jens Reimer, David J Nutt, et al.
Psychopharmacology|September 23, 2014
LSD enhances suggestibility in healthy volunteersR L Carhart-Harris, M Kaelen, M G Whalley, et al.
Neuropharmacology|October 17, 2022
Mescaline: The forgotten psychedelicIoanna A Vamvakopoulou, Kelly A D Narine, Ian Campbell, et al.
Pageof 79